MSFT Stock Today: April 9 Musk Push to Oust Altman Tests OpenAI Tie-Up

Sam Altman lawsuit headlines intensified on April 9 as Elon Musk moved to oust Sam Altman and Greg Brockman. That raises governance risk for the Microsoft OpenAI partnership at the core of MSFT’s AI plans. MSFT recently traded at $374.33 after a soft start to April. With earnings on April 29, management’s comments on access to OpenAI models and spend will matter. For Singapore investors, we think legal updates, AI adoption metrics, and price levels should guide entries, risk, and position size. All figures are quoted in USD unless noted.

What Musk’s Push Means for Microsoft

Elon Musk’s filing seeks removal of Sam Altman and Greg Brockman and a reversion of OpenAI to a nonprofit, with a late April jury trial expected. OpenAI has asked state attorneys general to review alleged anti‑competitive behavior by Musk. This tug of war keeps the Sam Altman lawsuit in focus, raising uncertainty around model access, support, and roadmap timing for Microsoft. See coverage from CNBC.

Microsoft’s Copilot and Azure OpenAI Services rely on predictable model supply, support, and licensing. Any disruption from the Sam Altman lawsuit could push customers to diversify providers or slow deployments. That risk comes as investment needs stay high. Microsoft’s capex to revenue is 27.20%, and R&D to revenue is 11.03%, underscoring spend sensitivity to AI adoption and contract clarity.

Stock Setup: Price, Trend, and Key Levels

MSFT is at $374.33, below the 50‑day average of $402.04 and the 200‑day average of $476.39. Day range is $371.41 to $385.00, with ATR at 8.82 showing active daily swings. The Bollinger middle band is $380.21, a near‑term pivot. Price action remains cautious as the Microsoft OpenAI partnership headlines filter through. All prices are in USD.

RSI is 39.71, showing weak momentum, while the MACD histogram turned positive at 1.11, hinting at early improvement. ADX is 34.73, a strong trend reading that still favors the bears. Bollinger support sits near $351.70 and the upper band at $408.73. Legal news around the Sam Altman lawsuit may drive tests of these bounds.

Earnings Catalyst and Street View

Earnings are set for April 29. We will watch Azure growth, Copilot seat expansion, and comments on OpenAI model access and pricing. With capex to revenue at 27.20% and R&D at 11.03%, spend discipline will be key. Any change tied to the Sam Altman lawsuit could influence guidance, customer mix, or AI gross margins.

Street views remain constructive: 56 Buy, 2 Hold, and 0 Sell. The P/E is 23.18 with a 39.04% net margin and a 0.93% dividend yield. Meyka’s Stock Grade is A, Suggestion BUY, while our composite Company Rating is B+ with a Neutral stance. The Elon Musk lawsuit keeps a headline overhang even with strong profitability.

Singapore Investor Angle

Singapore investors face USD exposure on a US technology name. Consider multi‑step sizing and stop‑loss placement that respects daily swings, with ATR at 8.82 as a guide. Concentration risk is real because AI features link closely to the Microsoft OpenAI partnership. Use staggered buys or a core‑satellite plan to balance conviction with legal and product risks.

Near term, we like tracking filings and decisions tied to the Sam Altman lawsuit, plus trial timing and any remedies. For context, OpenAI urged state probes of Musk’s behavior, as reported by Channel NewsAsia. Watch $352 to $408 as a trading range and monthly model forecasts near $404.46. Adjust plans if guidance shifts or model access changes.

Final Thoughts

The Sam Altman lawsuit has moved from background noise to a near‑term driver for MSFT. For us, the base case is continued access to OpenAI models, but terms or oversight could shift. That keeps focus on product continuity, Azure AI growth, and spend discipline into the April 29 report. Technically, price sits below key averages, with RSI weak and an ADX that signals a firm trend. We think Singapore investors can keep positions sized to volatility, use the $352 to $408 range for timing, and watch legal filings and management commentary for confirmation. If guidance is steady and AI adoption holds, the upside case improves. If access or pricing wobbles, patience and tighter risk controls make sense.

FAQs

Disclaimer:

The content shared by Meyka AI PTY LTD is solely for research and informational purposes.  Meyka is not a financial advisory service, and the information provided should not be considered investment or trading advice.